Clinical Trials Browser

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × Inhalation × Clear all

NCT06896890 2025-03-26

Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Respiratory Aspiration